We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+9.86%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$27.9B
AUM Growth
+$6.35B
(+29%)
Cap. Flow
+$3.76B
Cap. Flow
% of AUM
13.48%
Top 10 Holdings %
Top 10 Hldgs %
12.67%
Holding
2,368
New
371
Increased
836
Reduced
637
Closed
381
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$228M |
| 2 |
Coca-Cola
KO
|
+$167M |
| 3 |
Apple
AAPL
|
+$131M |
| 4 |
Mondelez International
MDLZ
|
+$121M |
| 5 |
UnitedHealth
UNH
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Public Storage
PSA
|
+$80.2M |
| 2 |
Dollar General
DG
|
+$74M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$69.1M |
| 4 |
Citizens Financial Group
CFG
|
+$67.8M |
| 5 |
Booking.com
BKNG
|
+$63.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.75% |
| 2 | Healthcare | 15.02% |
| 3 | Consumer Discretionary | 12.4% |
| 4 | Financials | 11.54% |
| 5 | Industrials | 11.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Byrna Technologies
BYRN
$80.3M
| $129K | ﹤0.01% |
+16,408
| New | +$123K |
|
1752
Voyager Therapeutics
VYGR
$187M
| $129K | ﹤0.01% |
+21,077
| New | +$120K |
|
1753
Cato Corp
CATO
$65.9M
| $128K | ﹤0.01% |
+13,734
| New | +$140K |
|
1754
ClearPoint Neuro
CLPT
$423M
| $128K | ﹤0.01% |
+15,124
| New | +$143K |
|
|
GATO
1755
DELISTED
Gatos Silver, Inc.
GATO
| $128K | ﹤0.01% |
+31,243
| New | +$113K |
|
|
BCOV
1756
DELISTED
Brightcove, Inc.
BCOV
| $128K | ﹤0.01% |
24,400
| – | – |
|
1757
Archrock
AROC
$6.33B
| $128K | ﹤0.01% |
14,200
-2,631
| -16% | -$21.1K |
|
1758
Compass Therapeutics
CMPX
$373M
| $127K | ﹤0.01% |
+25,305
| New | +$101K |
|
1759
UroGen Pharma
URGN
$2B
| $127K | ﹤0.01% |
+14,300
| New | +$135K |
|
1760
Prelude Therapeutics
PRLD
$305M
| $127K | ﹤0.01% |
+20,994
| New | +$135K |
|
1761
W&T Offshore
WTI
$545M
| $126K | ﹤0.01% |
22,628
-5,937
| -21% | -$40.9K |
|
1762
Wave Life Sciences
WVE
$1.12B
| $125K | ﹤0.01% |
+17,842
| New | +$82.2K |
|
1763
StoneCo
STNE
$2.62B
| $124K | ﹤0.01% |
13,122
-136,381
| -91% | -$1.43M |
|
|
DCH
1764
Dauch Corp
DCH
$1.3B
| $123K | ﹤0.01% |
+15,715
| New | +$141K |
|
|
WE
1765
DELISTED
WeWork Inc.
WE
| $122K | ﹤0.01% |
+2,133
| New | +$200K |
|
1766
Tactile Systems Technology
TCMD
$620M
| $121K | ﹤0.01% |
+10,565
| New | +$93K |
|
1767
Cabaletta Bio
CABA
$439M
| $120K | ﹤0.01% |
+13,021
| New | +$47.4K |
|
1768
BioAtla
BCAB
$5.59M
| $120K | ﹤0.01% |
292
+59
| +25% | +$24.5K |
|
|
YELL
1769
DELISTED
Yellow Corporation Common Stock
YELL
| $120K | ﹤0.01% |
47,826
+37,424
| +360% | +$133K |
|
1770
Lineage Cell Therapeutics
LCTX
$257M
| $120K | ﹤0.01% |
+102,396
| New | +$129K |
|
|
LUNA
1771
DELISTED
Luna Innovations Incorporated
LUNA
| $118K | ﹤0.01% |
+13,419
| New | +$85K |
|
1772
Janus International
JBI
$722M
| $118K | ﹤0.01% |
12,357
+1,357
| +12% | +$13.1K |
|
|
VOXX
1773
DELISTED
VOXX International Corporation Class A
VOXX
| $117K | ﹤0.01% |
+13,938
| New | +$126K |
|
1774
Acumen Pharmaceuticals
ABOS
$154M
| $116K | ﹤0.01% |
+21,529
| New | +$145K |
|
1775
Harvard Bioscience
HBIO
$27.1M
| $113K | ﹤0.01% |
4,097
+1,663
| +68% | +$41K |
|
Similar funds
Man Group's Q4 2022 Portfolio in Review
As of Q4 2022, Man Group held 2,368 positions worth $27.9B, up 29% from $21.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Man Group deployed $3.76B of net new capital in Q4 2022, opening 371 new positions and adding to 836 existing holdings. Its largest new stake was Textron: 910,556 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Public Storage, an estimated $80.2M trimmed.
- Man Group's largest Q4 2022 buy was Textron: 910,556 shares worth $64.5M.
- Man Group added most to PepsiCo in Q4 2022, an estimated $228M increase.
- Man Group's biggest Q4 2022 reduction was Public Storage, cutting an estimated $80.2M.
- Man Group fully exited ZENDESK INC in Q4 2022, selling an estimated $69.1M.
- Man Group's ten largest holdings make up 13% of its $27.9B portfolio in Q4 2022.
- Man Group opened 371 new positions and closed 381 in Q4 2022.
- Man Group's portfolio value rose 29% quarter-over-quarter to $27.9B.
Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.